China International Pharmaceutical Machinery Expo

Meet the Watson-Marlow team at CIPM

15 - 17 October 2022

Drug manufacturers are increasingly adopting continuous bioprocessing to manufacture biologics as efficiently as possible. This is being driven by a need to reduce production costs and prices of pharmaceutical products. Furthermore, the FDA has stated its support for the implementation of continuous bioprocessing. A key consequence of continuous bioprocessing is that single-use components and assemblies must maintain integrity for process cycle times of up to 90 days.

Meet specialist engineers from across Watson-Marlow Fluid Technology Solutions and explore our diverse product range and how our fluid path technologies can help your bioprocesses.

Visit the exhibition website